CG肿瘤制药 CGON
$75.99 +$11.19 (+17.27%)
休市 · Nov 7, 10:50 pm ET · 最新盘后价 $76.05 +0.08%
开盘$66.49
昨收$64.80
当日区间$66.17 – $80.03
成交量3.66M
市值$6.74B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$1.16M
营业利润-$86.40M-77.3% YoY
净利润-$79.06M-90.8% YoY
摊薄每股收益-$0.90-66.7% YoY
自由现金流-$46.88M-67.6% YoY
经营现金流-$46.41M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率-85.2%
营业利润率-4,056.2%
净利率-3,602.7%
净资产收益率-26.4%
资产收益率-25.1%
投入资本回报率-29.6%
流动比率22.22
负债/资产比率5.2%
现金及投资$1.03B
总负债$7.83M
净现金（净负债）$1.02B
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $1.16M | $1.08M | $4.04M | $2.32M | $1.67M |
| 营业总收入 | $1.16M | $1.08M | $4.04M | $2.32M | $1.67M |
| 营业成本 | $3.93M | $2.96M | $4.65M | $3.07M | $1.58M |
| 毛利润 | -$2.77M | -$1.88M | -$607,000.00 | -$748,000.00 | $89,000.00 |
| 营业费用 | $83.63M | $64.51M | $190.17M | $47.95M | $51.22M |
| 销售及管理费用 | $28.98M | $20.78M | $73.53M | $17.99M | $23.33M |
| -管理费用 | $28.98M | $20.78M | $73.53M | $17.99M | $23.33M |
| 研发费用 | $54.66M | $43.73M | $116.64M | $29.96M | $27.88M |
| 营业利润 | -$86.40M | -$66.39M | -$190.77M | -$48.70M | -$51.13M |
| 非经营性利息净收入（支出） | $7.33M | $6.29M | $29.93M | $7.44M | $7.42M |
| 非经营性利息收入 | $7.33M | $6.29M | $29.93M | $7.44M | $7.42M |
| 其他收入（支出） | $16,000.00 | -$101,000.00 | -$152,000.00 | -$53,000.00 | -$100,000.00 |
| 其他非经营性收入（支出） | $16,000.00 | -$101,000.00 | -$152,000.00 | -$53,000.00 | -$100,000.00 |
| 税前利润 | -$79.06M | -$60.20M | -$161.00M | -$41.31M | -$43.81M |
| 净利润 | -$79.06M | -$60.20M | -$161.00M | -$41.31M | -$43.81M |
| 持续经营利润 | -$79.06M | -$60.20M | -$161.00M | -$41.31M | -$43.81M |
| 归属母公司净利润 | -$79.06M | -$60.20M | -$161.00M | -$41.31M | -$43.81M |
| 归属普通股股东净利润 | -$79.06M | -$60.20M | -$161.00M | -$41.31M | -$43.81M |
| 基本每股收益 | -$0.90 | -$0.71 | -$2.08 | -$0.51 | -$0.57 |
| 摊薄每股收益 | -$0.90 | -$0.71 | -$2.08 | -$0.51 | -$0.57 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $1.09B | $1.14B | $791.59M | $791.59M | $729.91M |
| 流动资产合计 | $1.05B | $1.10B | $759.48M | $759.48M | $695.79M |
| 现金及现金等价物与短期投资 | $1.03B | $1.08B | $742.16M | $742.16M | $680.26M |
| -现金及现金等价物 | $19.64M | $33.70M | $32.49M | $32.49M | $45.15M |
| -短期投资 | $1.01B | $1.04B | $709.67M | $709.67M | $635.12M |
| 应收款 | $417,000.00 | $1.28M | $688,000.00 | $688,000.00 | $515,000.00 |
| -应收账款 | $417,000.00 | $1.28M | $688,000.00 | $688,000.00 | $515,000.00 |
| 存货 | $1.00M | $1.49M | $1.57M | $1.57M | $1.50M |
| 其他流动资产 | $19.95M | $23.13M | $15.07M | $15.07M | $13.51M |
| 非流动资产合计 | $36.01M | $33.12M | $32.12M | $32.12M | $34.12M |
| 固定资产净值 | $20.44M | $19.59M | $19.57M | $19.57M | $19.53M |
| -固定资产原值 | $23.57M | $21.88M | $21.04M | $21.04M | $20.16M |
| -累计折旧 | -$3.13M | -$2.29M | -$1.47M | -$1.47M | -$623,000.00 |
| 商誉及其他无形资产 | $10.84M | $10.86M | $10.87M | $10.87M | $14.48M |
| -商誉 | $10.30M | $10.30M | $10.30M | $10.30M | $12.81M |
| -其他无形资产 | $545,000.00 | $560,000.00 | $575,000.00 | $575,000.00 | $1.67M |
| 其他非流动资产 | $4.73M | $2.68M | $1.68M | $1.68M | $114,000.00 |
| 负债合计 | $56.54M | $43.48M | $38.99M | $38.99M | $42.27M |
| 流动负债合计 | $47.24M | $35.22M | $30.84M | $30.84M | $30.53M |
| 应付款 | $12.73M | $8.24M | $5.71M | $5.71M | $9.19M |
| -应付账款 | $12.73M | $8.24M | $5.71M | $5.71M | $9.19M |
| 一年内应计费用 | $26.27M | $20.95M | $14.90M | $14.90M | $13.54M |
| 短期债务及融资租赁负债 | $985,000.00 | $1.07M | $915,000.00 | $915,000.00 | $912,000.00 |
| -一年内到期融资租赁负债 | $985,000.00 | $1.07M | $915,000.00 | $915,000.00 | $912,000.00 |
| 一年内递延负债 | $226,000.00 | $254,000.00 | $286,000.00 | $286,000.00 | $259,000.00 |
| 其他流动负债 | $1.45M | $1.71M | $802,000.00 | $802,000.00 | $544,000.00 |
| 非流动负债合计 | $9.30M | $8.27M | $8.15M | $8.15M | $11.74M |
| 长期债务及融资租赁负债 | $7.83M | $6.51M | $6.11M | $6.11M | $6.33M |
| -长期债务 | $3.00M | $3.00M | $3.00M | $3.00M | $3.00M |
| -长期融资租赁负债 | $4.83M | $3.51M | $3.11M | $3.11M | $3.33M |
| 一年以上递延负债 | $307,000.00 | $307,000.00 | $307,000.00 | $307,000.00 | $1.61M |
| 其他非流动负债 | $1.16M | $1.45M | $1.74M | $1.74M | $3.80M |
| 股东权益合计 | $1.03B | $1.09B | $752.60M | $752.60M | $687.64M |
| 股东权益 | $1.03B | $1.09B | $752.60M | $752.60M | $687.64M |
| 股本 | $9,000.00 | $9,000.00 | $8,000.00 | $8,000.00 | $8,000.00 |
| -普通股 | $9,000.00 | $9,000.00 | $8,000.00 | $8,000.00 | $8,000.00 |
| 资本公积 | $1.55B | $1.53B | $1.13B | $1.13B | $1.03B |
| 留存收益 | -$518.23M | -$439.18M | -$378.98M | -$378.98M | -$337.67M |
| -优先股 | – | – | – | – | $0.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$46.41M | -$56.94M | -$132.35M | -$36.22M | -$38.89M |
| 持续经营经营活动现金流净额 | -$46.41M | -$56.94M | -$132.35M | -$36.22M | -$38.89M |
| 持续经营净利润 | -$79.06M | -$60.20M | -$161.00M | -$41.31M | -$43.81M |
| 折旧、折耗与摊销 | $850,000.00 | $841,000.00 | $1.45M | $849,000.00 | $416,000.00 |
| 其他非现金项目 | $71,000.00 | $59,000.00 | -$734,000.00 | $89,000.00 | -$161,000.00 |
| 营运资金变动 | $14.38M | -$5.78M | $2.28M | -$3.98M | -$2.87M |
| -应收款变动 | $858,000.00 | -$587,000.00 | -$320,000.00 | -$301,000.00 | -$19,000.00 |
| -存货变动 | $490,000.00 | $72,000.00 | -$444,000.00 | -$64,000.00 | -$380,000.00 |
| -预付资产变动 | $3.18M | -$8.07M | -$1.90M | -$1.81M | -$324,000.00 |
| -应付账款及应计费用变动 | $12.23M | $4.13M | $7.01M | $252,000.00 | -$2.15M |
| -其他流动资产变动 | -$2.05M | -$998,000.00 | -$1.58M | -$1.56M | -$7,000.00 |
| -其他流动负债变动 | -$325,000.00 | -$329,000.00 | -$487,000.00 | -$496,000.00 | $9,000.00 |
| 投资活动现金流净额 | $30.43M | -$334.85M | -$245.82M | -$75.51M | $15.05M |
| 持续经营投资活动现金流净额 | $30.43M | -$334.85M | -$245.82M | -$75.51M | $15.05M |
| 固定资产购置及出售净额 | -$468,000.00 | -$304,000.00 | -$134,000.00 | -$7,000.00 | -$97,000.00 |
| 投资购置及出售净额 | $30.90M | -$334.54M | -$223.72M | -$75.50M | $11.11M |
| 筹资活动现金流 | $1.92M | $393.00M | $153.59M | $99.07M | $54.37M |
| 持续经营筹资活动现金流净额 | $1.92M | $393.00M | $153.59M | $99.07M | $54.37M |
| 普通股发行净额 | $0.00 | $391.55M | $147.45M | $98.45M | $49.00M |
| 股票期权行使所得 | $2.08M | $1.67M | $6.46M | $656,000.00 | $5.10M |
| 其他筹资费用净额 | -$159,000.00 | -$221,000.00 | -$316,000.00 | -$39,000.00 | $270,000.00 |
| 期末现金余额 | $19.64M | $33.70M | $32.49M | $32.49M | $45.15M |
| 现金净变动 | -$14.06M | $1.21M | -$224.58M | -$12.66M | $30.52M |
| 期初现金余额 | $33.70M | $32.49M | $257.07M | $45.15M | $14.62M |
| 自由现金流 | -$46.88M | -$57.25M | -$132.48M | -$36.22M | -$38.99M |
| 业务购买及出售净额 | – | – | -$21.97M | $0.00 | – |
| 债务发行及偿还净额 | – | – | $0.00 | $0.00 | – |
| 优先股发行净额 | – | – | $0.00 | – | – |
暂无评论——快来第一个聊聊 CGON。
登录后参与讨论。